Litcius/Paper detail

A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Umair Mahmood, Andrew Bang, Yu‐Hui Chen, Raymond H. Mak, Jochen H. Lorch, Glenn J. Hanna, Mizuki Nishino, Claire Manuszak, Emily M. Thrash, Mariano Severgnini, Matthew R. Sanborn, Vishwajith Sridharan, Danielle N. Margalit, Roy B. Tishler, Paul M. Busse, Henning Willers, Harvey J. Mamon, Hyung‐Jin Yoo, Sara I. Pai, Lori J. Wirth, Robert I. Haddad, Nicole G. Chau, Jonathan D. Schoenfeld

2020International Journal of Radiation Oncology*Biology*Physics111 citationsDOIOpen Access PDF

Topics & Concepts

Adenoid cystic carcinomaPembrolizumabMedicineOncologyInternal medicineCarcinomaCancerImmunotherapySalivary Gland Tumors Diagnosis and TreatmentColorectal and Anal CarcinomasHead and Neck Surgical Oncology
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma | Litcius